These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35501119)

  • 21. Genome-wide association studies of exacerbations in children using long-acting beta2-agonists.
    Slob EMA; Richards LB; Vijverberg SJH; Longo C; Koppelman GH; Pijnenburg MWH; Bel EHD; Neerincx AH; Herrera Luis E; Perez-Garcia J; Tim Chew F; Yie Sio Y; Andiappan AK; Turner SW; Mukhopadhyay S; Palmer CNA; Hawcutt D; Jorgensen AL; Burchard EG; Hernandez-Pacheco N; Pino-Yanes M; Maitland-van der Zee AH
    Pediatr Allergy Immunol; 2021 Aug; 32(6):1197-1207. PubMed ID: 33706416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation is associated with inhaled corticosteroid response in persistent childhood asthmatics.
    Wang AL; Gruzieva O; Qiu W; Kebede Merid S; Celedón JC; Raby BA; Söderhäll C; DeMeo DL; Weiss ST; Melén E; Tantisira KG
    Clin Exp Allergy; 2019 Sep; 49(9):1225-1234. PubMed ID: 31187518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
    Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Voorhies K; Mohammed A; Chinthala L; Kong SW; Lee IH; Kho AT; McGeachie M; Mandl KD; Raby B; Hayes M; Davis RL; Wu AC; Lutz SM
    Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.
    Stanford RH; Blanchette CM; Roberts MH; Petersen H; Fuhlbrigge AL
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):343-51. PubMed ID: 23083688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
    Cates CJ; Karner C
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omalizumab for asthma in adults and children.
    Normansell R; Walker S; Milan SJ; Walters EH; Nair P
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A polymorphism in the histone deacetylase 1 gene is associated with the response to corticosteroids in asthmatics.
    Kim MH; Kim SH; Kim YK; Hong SJ; Min KU; Cho SH; Park HW
    Korean J Intern Med; 2013 Nov; 28(6):708-14. PubMed ID: 24307847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
    Kew KM; Dahri K
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroid plus β
    Wang G; Zhang X; Zhang HP; Wang L; Kang Y; Barnes PJ; Wang G
    Respir Res; 2017 Dec; 18(1):203. PubMed ID: 29207999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus.
    Tantisira KG; Damask A; Szefler SJ; Schuemann B; Markezich A; Su J; Klanderman B; Sylvia J; Wu R; Martinez F; Boushey HA; Chinchilli VM; Mauger D; Weiss ST; Israel E;
    Am J Respir Crit Care Med; 2012 Jun; 185(12):1286-91. PubMed ID: 22538805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
    Beasley R; Harrison T; Peterson S; Gustafson P; Hamblin A; Bengtsson T; Fagerås M
    JAMA Netw Open; 2022 Mar; 5(3):e220615. PubMed ID: 35230437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exhaled nitric oxide continues to reflect airway hyperresponsiveness and disease activity in inhaled corticosteroid-treated adult asthmatic patients.
    Reid DW; Johns DP; Feltis B; Ward C; Walters EH
    Respirology; 2003 Dec; 8(4):479-86. PubMed ID: 14629652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variation in uncontrolled childhood asthma despite ICS treatment.
    Leusink M; Vijverberg SJ; Koenderman L; Raaijmakers JA; de Jongste JC; Sterk PJ; Duiverman EJ; Onland-Moret NC; Postma DS; de Boer A; de Bakker PI; Koppelman GH; Maitland-van der Zee AH
    Pharmacogenomics J; 2016 Apr; 16(2):158-63. PubMed ID: 25963336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.
    Edmonds ML; Milan SJ; Camargo CA; Pollack CV; Rowe BH
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002308. PubMed ID: 23235589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetic analysis of GLCCI1 in three north European pediatric asthma populations with a reported use of inhaled corticosteroids.
    Vijverberg SJ; Tavendale R; Leusink M; Koenderman L; Raaijmakers JA; Postma DS; Koppelman GH; Turner SW; Mukhopadhyay S; Palmer CN; Maitland-van der Zee AH
    Pharmacogenomics; 2014 Apr; 15(6):799-806. PubMed ID: 24897287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STOP: an open label crossover trial to study ICS withdrawal in patients with a combination of obesity and low-inflammatory asthma and evaluate its effect on asthma control and quality of life.
    Witte JA; Braunstahl GJ; Blox WJB; van 't Westeinde SC; In 't Veen JCCM; Kappen JH; van Rossum EFC
    BMC Pulm Med; 2022 Feb; 22(1):53. PubMed ID: 35123457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
    Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.